S&P 500   3,347.84 (-0.38%)
DOW   27,822.17 (+0.11%)
QQQ   268.47 (-0.68%)
AAPL   439.61 (-2.51%)
MSFT   204.60 (-1.75%)
FB   260.84 (-0.82%)
GOOGL   1,494.50 (-0.15%)
AMZN   3,101.28 (-1.49%)
NVDA   435.69 (-2.45%)
CGC   17.27 (-3.68%)
BABA   249.75 (+0.65%)
TSLA   1,381.27 (-2.63%)
GE   6.78 (+1.65%)
MU   48.60 (-1.12%)
AMD   77.43 (-5.85%)
T   30.32 (+0.40%)
F   7.30 (+2.96%)
ACB   10.19 (-0.29%)
GILD   68.19 (-0.47%)
NFLX   470.18 (-2.73%)
DIS   131.36 (+2.00%)
BAC   27.29 (+2.75%)
BA   185.56 (+3.43%)
S&P 500   3,347.84 (-0.38%)
DOW   27,822.17 (+0.11%)
QQQ   268.47 (-0.68%)
AAPL   439.61 (-2.51%)
MSFT   204.60 (-1.75%)
FB   260.84 (-0.82%)
GOOGL   1,494.50 (-0.15%)
AMZN   3,101.28 (-1.49%)
NVDA   435.69 (-2.45%)
CGC   17.27 (-3.68%)
BABA   249.75 (+0.65%)
TSLA   1,381.27 (-2.63%)
GE   6.78 (+1.65%)
MU   48.60 (-1.12%)
AMD   77.43 (-5.85%)
T   30.32 (+0.40%)
F   7.30 (+2.96%)
ACB   10.19 (-0.29%)
GILD   68.19 (-0.47%)
NFLX   470.18 (-2.73%)
DIS   131.36 (+2.00%)
BAC   27.29 (+2.75%)
BA   185.56 (+3.43%)
S&P 500   3,347.84 (-0.38%)
DOW   27,822.17 (+0.11%)
QQQ   268.47 (-0.68%)
AAPL   439.61 (-2.51%)
MSFT   204.60 (-1.75%)
FB   260.84 (-0.82%)
GOOGL   1,494.50 (-0.15%)
AMZN   3,101.28 (-1.49%)
NVDA   435.69 (-2.45%)
CGC   17.27 (-3.68%)
BABA   249.75 (+0.65%)
TSLA   1,381.27 (-2.63%)
GE   6.78 (+1.65%)
MU   48.60 (-1.12%)
AMD   77.43 (-5.85%)
T   30.32 (+0.40%)
F   7.30 (+2.96%)
ACB   10.19 (-0.29%)
GILD   68.19 (-0.47%)
NFLX   470.18 (-2.73%)
DIS   131.36 (+2.00%)
BAC   27.29 (+2.75%)
BA   185.56 (+3.43%)
S&P 500   3,347.84 (-0.38%)
DOW   27,822.17 (+0.11%)
QQQ   268.47 (-0.68%)
AAPL   439.61 (-2.51%)
MSFT   204.60 (-1.75%)
FB   260.84 (-0.82%)
GOOGL   1,494.50 (-0.15%)
AMZN   3,101.28 (-1.49%)
NVDA   435.69 (-2.45%)
CGC   17.27 (-3.68%)
BABA   249.75 (+0.65%)
TSLA   1,381.27 (-2.63%)
GE   6.78 (+1.65%)
MU   48.60 (-1.12%)
AMD   77.43 (-5.85%)
T   30.32 (+0.40%)
F   7.30 (+2.96%)
ACB   10.19 (-0.29%)
GILD   68.19 (-0.47%)
NFLX   470.18 (-2.73%)
DIS   131.36 (+2.00%)
BAC   27.29 (+2.75%)
BA   185.56 (+3.43%)
Log in

NASDAQ:RTIXRTI Surgical Stock Price, Forecast & News

$3.14
0.00 (0.00 %)
(As of 07/22/2020)
Add
Compare
Today's Range
$3.12
Now: $3.14
$3.30
50-Day Range
$2.70
MA: $3.13
$4.55
52-Week Range
$1.46
Now: $3.14
$5.40
Volume686,036 shs
Average Volume823,396 shs
Market Capitalization$234.24 million
P/E RatioN/A
Dividend YieldN/A
Beta2.14
RTI Surgical Holdings, Inc., a surgical implant company, designs, develops, manufactures, and distributes biologic, metal, and synthetic implants worldwide. It processes donated human musculoskeletal and other tissues, as well as bovine and porcine animal tissues to produce allograft and xenograft implants by using its proprietary BIOCLEANSE, TUTOPLAST, and CANCELLE SP sterilization processes. The company's implants are used in the fields of orthopedic, spine, sports medicine, general surgery, trauma and other surgical procedures to repair and promote the natural healing of human bone and other human tissues; and to enhance surgical outcomes. It markets its products through its direct distribution force, as well as through a network of independent distributors. RTI Surgical Holdings, Inc. was founded in 1997 and is based in Deerfield, Illinois.
Read More
RTI Surgical logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.47 out of 5 stars


Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryHealth Care Supplies
SectorMedical
Current SymbolNASDAQ:RTIX
CUSIP74975N10
Phone386-418-8888

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$308.38 million
Cash Flow$0.30 per share
Book Value$2.89 per share

Profitability

Net Income$-211,640,000.00

Miscellaneous

Employees891
Market Cap$234.24 million
Next Earnings Date9/30/2020 (Estimated)
OptionableOptionable
$3.14
0.00 (0.00 %)
(As of 07/22/2020)
30 days | 90 days | 365 days | Advanced Chart

Receive RTIX News and Ratings via Email

Sign-up to receive the latest news and ratings for RTIX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











RTI Surgical (NASDAQ:RTIX) Frequently Asked Questions

How has RTI Surgical's stock been impacted by Coronavirus (COVID-19)?

RTI Surgical's stock was trading at $3.09 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, RTIX stock has increased by 1.6% and is now trading at $3.14.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of RTI Surgical?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for RTI Surgical in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for RTI Surgical
.

When is RTI Surgical's next earnings date?

RTI Surgical is scheduled to release its next quarterly earnings announcement on Wednesday, September 30th 2020.
View our earnings forecast for RTI Surgical
.

How were RTI Surgical's earnings last quarter?

RTI Surgical Holdings Inc (NASDAQ:RTIX) released its earnings results on Monday, June, 8th. The medical equipment provider reported ($0.16) earnings per share for the quarter. The medical equipment provider had revenue of $80.21 million for the quarter.
View RTI Surgical's earnings history
.

What price target have analysts set for RTIX?

2 brokers have issued twelve-month price targets for RTI Surgical's shares. Their forecasts range from $5.00 to $5.00. On average, they anticipate RTI Surgical's share price to reach $5.00 in the next year. This suggests a possible upside of 59.2% from the stock's current price.
View analysts' price targets for RTI Surgical
.

Has RTI Surgical been receiving favorable news coverage?

News articles about RTIX stock have trended neutral recently, InfoTrie Sentiment reports. InfoTrie scores the sentiment of news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. RTI Surgical earned a news sentiment score of 0.2 on InfoTrie's scale. They also assigned press coverage about the medical equipment provider a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the near future.
View the latest news about RTI Surgical
.

Are investors shorting RTI Surgical?

RTI Surgical saw a decrease in short interest in January. As of January 31st, there was short interest totaling 1,050,000 shares, a decrease of 27.1% from the January 15th total of 1,440,000 shares. Based on an average daily trading volume, of 463,200 shares, the days-to-cover ratio is presently 2.3 days. Approximately 1.5% of the company's stock are short sold.
View RTI Surgical's Short Interest
.

Who are some of RTI Surgical's key competitors?

What other stocks do shareholders of RTI Surgical own?

Who are RTI Surgical's key executives?

RTI Surgical's management team includes the following people:
  • Mr. Camille I. Farhat, CEO, Pres & Director (Age 49)
  • Mr. Jonathon M. Singer, Chief Financial & Admin. Officer and Corp. Sec. (Age 55)
  • Mr. John N. Varela, Exec. VP of Global Operations (Age 52)
  • Mr. Tony Lemus, VP of Global R&D, Clinical and Regulatory
  • Ms. Molly Poarch, Director of Corp. Communications

What is RTI Surgical's stock symbol?

RTI Surgical trades on the NASDAQ under the ticker symbol "RTIX."

Who are RTI Surgical's major shareholders?

RTI Surgical's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Paradigm Capital Management Inc. NY (6.57%), UBS Group AG (0.18%), Dfpg Investments LLC (0.14%), Strs Ohio (0.11%), Assenagon Asset Management S.A. (0.11%) and Dupont Capital Management Corp (0.11%). Company insiders that own RTI Surgical stock include Camille Farhat and Jonathon M Singer.
View institutional ownership trends for RTI Surgical
.

Which institutional investors are selling RTI Surgical stock?

RTIX stock was sold by a variety of institutional investors in the last quarter, including Paradigm Capital Management Inc. NY, and UBS Group AG.
View insider buying and selling activity for RTI Surgical
.

Which institutional investors are buying RTI Surgical stock?

RTIX stock was bought by a variety of institutional investors in the last quarter, including Dfpg Investments LLC, Assenagon Asset Management S.A., Dupont Capital Management Corp, Mackay Shields LLC, Principal Financial Group Inc., Virtu Financial LLC, Chicago Partners Investment Group LLC, and SG Americas Securities LLC. Company insiders that have bought RTI Surgical stock in the last two years include Camille Farhat, and Jonathon M Singer.
View insider buying and selling activity for RTI Surgical
.

How do I buy shares of RTI Surgical?

Shares of RTIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is RTI Surgical's stock price today?

One share of RTIX stock can currently be purchased for approximately $3.14.

How big of a company is RTI Surgical?

RTI Surgical has a market capitalization of $234.24 million and generates $308.38 million in revenue each year. The medical equipment provider earns $-211,640,000.00 in net income (profit) each year or ($0.16) on an earnings per share basis. RTI Surgical employs 891 workers across the globe.

What is RTI Surgical's official website?

The official website for RTI Surgical is www.rtix.com.

How can I contact RTI Surgical?

RTI Surgical's mailing address is 11621 RESEARCH CIRCLE, ALACHUA FL, 32615. The medical equipment provider can be reached via phone at 386-418-8888 or via email at [email protected]

This page was last updated on 8/11/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.